A survey of arylamine N-acetyltransferase activity in common fruits and vegetables

Journal of Food Biochemistry

Volumn 20, Issue 4, 1996, Pages 481-490

  Chung, J G ^a   Lee, J H ^a   Ho, C C ^a   Lai, J M ^a   Chou, Y C ^a   Teng, H H ^a   Hung, C F ^b   Huang, S C ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b JEN AI HOSPITAL   (Taiwan)

^c NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MOMORDICA CHARANTIA; PYRUS COMMUNIS;

EID: 0031501422     PISSN: 01458884     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-4514.1996.tb00571.x     Document Type: Review

References (27)

1. ANDRES, H.H. and WEBER, W.W. 1986. N-acetylation pharmacogenetics: Michaelis-Menten constants for arylamine drugs aspredicators of their N-acetylation rates in vivo. Drug Metabol. and Dispos. 14, 382-385.
2. BLUM, M., GRANT, D.M., DEMIERRE, A. and MYER, U.A. 1989a. Nucleotide sequence of a full length cDNA for arylamine N-acetyltransferase from rabbit liver. Nucleic Acids Res. 17, 3589-3595.
3. BLUM, G., GRANT, D.M., MCBRIDE, W., HEIN, M. and MYER, U.A. 1990. Human arylamine N-acetyltransferase genes: Isolation, chromosomal location, and functional expression. DNA Cell Biol. 9, 193-203.
4. BLUM, M., MEIM, M. and MYER, U.A. 1989b. Nucleotide sequence of rabbit NAT2 encoding polymorphic liver arylamine N-acetyltransferase (NAT). Nucleic Acid Res. 18, 5287-5295.
5. BRADFORD, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. CARTWRIGHT, R.A., GLASHAN, R.W., ROGERS, H.J., AHMAD, R.A., BARHAM-HALL, D., HIGGINS, E. and KAHN, M.A. 1982. The role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet 2, 842-846.
7. CASE, R.A.M., KOSKER, M.E., MCDONALD, D.B. and PEARSIN, J.T. 1954. Tumors of urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part I. The role of aniline, benzidine, alphanaphylamine and beta-anphthylamine. Br. J. Med. 11, 75-81.
8. CHUNG, J.G., GARRETT, L.R., BYERS, P.E. and CUCHENS, M.A. 1989. A survey of the amount of pristane in common fruits and vegetables. Journal of Food Composition and Analysis 2, 22-27.
9. CHUNG, J.G., KUO, H.M., LIN, T.H., HO, C.C., LEE, J.H., LAI, J.M., LEVY, G.N. and WEBER, W.W. 1996. Evidence for arylamine N-acetyltransferase in the Nematode Anisakis simplex. Cancer Lett. 106, 1-8.
10. CHUNG, J.G., LEVY, G.N. and WEBER, W.W. 1993. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-Nats slow acetylator congenic mice. Drug. Meta. Dispos. 21, 1057-1063.
11. GRANTS, D.M., BLUM, M, BEER, M. and MYERS, U.A. 1991. Monomorphic and polymorphic human arylamine N-acetyltransferase: A comparison of liver isozymes and expressed products of the two cloned genes. Mol. Pharmaco. 39, 184-191.
12. HEIN, D.W., KIRLIN, W.G., TRINIDAD, A., YEROKUN, T. and ANDREWS, A.F. 1987a. Human colon NAT activity towards carcinogenic arylamine substrates: Kinetic constants and partial purification. Pharmacolosist 29, 178-184.
13. HEIN, D.W., KIRLIN, W.G., YEROKUN, T. TRINIDAD, A. and OGOLLA, F. 1987b. Inheritance of acetylator genotype-dependent arylamine N-acetyltransferase in hamster bladder cytosol. Carcinogenesis 8, 1767-1774.
14. HEIN, D.W., OMICHINSKI, J.G., BREWER, T.A. and WEBER, W.W. 1982a. A unique pharmacogenic expression of the N-acetylation polymorphism in the inbred hamster. J. Pharmacol. Exp. Ther. 220, 8-15.
15. HEIN, D.W., SMOLEN, T.N., FOX, R.R. and WEBER, W.W. 1982b. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens imong established inbred rabbit strain. J. Pharmacol. Exp. Ther. 223, 40-44.
16. HO, C.C., LIN, T.H., LAI, Y.S., CHUNG, J.G., LEVY, G.N. and WEBER, W.W. 1996. Kinetics of acetyl CoA: arylamine N-acetyltransferase from rapid and slow acetylator frog tissues. Drug Metabol. and Disp. 42, 137-141.
17. ILETT, K.F., DAVID, B.M., DETCHON, P. CASTLEDON, M.W. and KWA, R. 1987. Acetylator phenotype in colorectal carcinoma. Cancer Res. 47, 1466-1469.
18. KILBANE, A.T., PETROFF, T. and WEBER, W.W. 1991. Kinetics of acetyl CoA: arylamine N-acetyltransferase from rapid and slow acetylator human liver. Drug Metabol. and Dispos. 19, 503-506.
19. LANG, N.P., CHU, D.Z.J., HUNTER, C.F., RONDALL, D.K., FLAMMANG, T.J. and KADLUBAR, F.F. 1986. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg. 121, 1259-1261.
20. LEVY, G.N., CHUNG, J.G. and WEBER, W.W. 1994. 2-Aminofluorene metabolism and DNA adduct formation by mononuclear leukocytes from rapid and slow acetylator mouse strains. Carcinogenesis 75, 353-357.
21. MARTELL, K.J., LEVY, G.N. and WEBER, W.W. 1992. Cloned mouse N-acetyltransferase: Enzymatic properties of expressed Nat-1 and Nat-2 gene product. Mol. Pharmacol. 42, 265-272.
22. MELICK, W.F., NARYKA, J.J. and KELLY, R.E. 1971. Bladder cancer due to exposure to para-aminobiphenyl. A. 17-year follow up. J. Urol. 106, 220-225.
23. TANNEN, R.H. and WEBER, W.W. 1980. Inheritance of acetylator phenotype in mice. J. Pharm. Exp. Ther. 273, 480-484.
24. VATSIS, K.P. and WEBER, W.W. 1993. Structural heterogenicity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch, of Biochem. and Biophy. 301, 71-76.
25. WAGNER, E.D., GENTLE, J.M. and PLEWA, M.J. 1990. Effects of specific monoxygenase and oxidase inhibitors on the activation of 2-aminofluorene by plant cells. Mutat. Res. 276, 163-167.
26. WEBER, W.W. 1987. The acetylator genes and drug response. Oxford.
27. WEBER, W.W., LEVY, G.N. and HEIN, D.W. 1990. Acetylation. In Conjugated reactions in drug metabolism; An integrated approach. (G.J. Mulder, ed.) pp. 163-191, Taylor and Francis LTD, London.